Navigation Links
ProFibrix Initiates Phase II Clinical Trial of its Lead Topical Hemostat Product Fibrocaps(TM)
Date:6/17/2009

SEATTLE, Washington, and LEIDEN, The Netherlands, June 18 /PRNewswire/ -- ProFibrix B.V. today announced the start of the company's Phase II clinical trial for Fibrocaps(TM), the company's lead topical Hemostat product, with the successful treatment of the first patients for mild to moderate bleeding during liver surgery. ProFibrix expects to complete the study before the end of 2009.

Fibrocaps is based on a mixture of two essential blood clotting proteins, fibrinogen and thrombin, and is a unique dry powder topical tissue sealant that rapidly stops bleeding after or during surgery. Fibrocaps has major advantages over existing liquid tissue sealants: it is ready for immediate use, is stable at room temperature, highly effective and fast acting.

ProFibrix expects to submit an Investigational New Drug Application (IND) for Fibrocaps to the U.S. Food and Drug Administration in the first half of 2010, and conduct a combined phase II/III pivotal study in various surgical indications.

Jaap Koopman, PhD, Chief Executive Officer, said: "The successful treatment of the first patients with our lead product Fibrocaps is an important milestone for the company. With focus and dedication we have made enormous progress over the past two years, and we are on track to bring Fibrocaps to the point of market approval."

About ProFibrix

ProFibrix was founded in 2004 and is headquartered in Leiden, The Netherlands, with a subsidiary in Seattle, WA. The company leverages its expertise in fibrinogen technology to develop and market innovative products for the hemostasis and regenerative medicine markets. Human fibrinogen plays a pivotal role in blood clotting and tissue healing. ProFibrix is led by a team with extensive commercial, clinical and scientific experience in the hemostasis field.


'/>"/>
SOURCE ProFibrix B.V.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. ProFibrix Steps up Recombinant Fibrinogen Program With PER.C6(R) License From Crucell
2. VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
3. AcelRx Initiates a Phase 2 Study to Evaluate Functionality of Its ARX-01 Sufentanil NanoTab PCA System
4. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
5. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
6. VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis
7. Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy
8. Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkins Lymphoma
9. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
10. Radius Initiates Phase 2a Clinical Trial of RAD1901 in Menopausal Hot Flashes
11. Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 21, 2015  Inmark,s acquisition of Saf-T-Pak last ... Goods Training, specifically Division 6.2.  For over 25 ... training programs focusing on IATA, ICAO, US DOT, ... "We were particularly interested in Saf-T-Pak,s ... multilingual internet training programs," said David Oyler ...
(Date:4/21/2015)... 21, 2015 Global cap & ... demand for caps and closures will exceed $55 billion in ... two trillion annually. Beverages will continue to account for well ... a number of smaller markets are expected to register faster ... Although the most developed markets -- the US, ...
(Date:4/21/2015)... 21, 2015 The global dermatology diagnostic devices ... 8.2% from 2014 to 2019. North America ... larger shares in the global dermatology diagnostic devices market. ... is mainly attributed to a wide range of factors, ... of dermatologists, and technological advancements made in the field ...
Breaking Medicine Technology:Inmark's Acquisition Of Saf-T-Pak Results In Expansion Of Its Dangerous Goods Training Portfolio 2World Caps & Closures Market 2World Caps & Closures Market 3Dermatology Diagnostic Devices Market by Product, by End-User - Global Forecast to 2019 2Dermatology Diagnostic Devices Market by Product, by End-User - Global Forecast to 2019 3
(Date:4/21/2015)... 21, 2015 The California Healthcare ... leading life sciences organizations, released the following statement ... California State Assembly Bill (AB) 463: , “As ... the development of treatments and cures for patients ... concerns regarding AB 463, the so-called Pharmaceutical Cost ...
(Date:4/21/2015)... City, NJ (PRWEB) April 21, 2015 ... collaboration across platforms and devices, today announced a new ... integration of the new Microsoft Office 365 Management Activity ... allows customers to fully audit and take action on ... environments. , “The new Office 365 Management Activity API ...
(Date:4/21/2015)... 2015 Lowcostcarinsuranceprice.com has released a new blog ... for SUVs. , SUVs are large vehicles that ... an SUV and a smaller regular car shows that passengers ... This makes SUV safer in crashes, but these large vehicles ... situation. , It is now possible to find low ...
(Date:4/21/2015)... 2015 Carinsurancehints.com has released a new ... their impact on auto insurance prices . ... insurance prices. Clients should review their insurance options before ... bought under several forms. Some of the popular policies ... can compare online rates and find the best prices ...
(Date:4/21/2015)... CA (PRWEB) April 21, 2015 Respected ... PACS® strategy , Visage Imaging Inc. (“Visage”), ... PME), has signed a seven-year contract with University ... in Northern Florida. The deal furthers the penetration ... hospital space, a key area of the North American ...
Breaking Medicine News(10 mins):Health News:California Healthcare Institute Statement on AB 463 2Health News:California Healthcare Institute Statement on AB 463 3Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 2Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 3Health News:Auto Insurance Quotes For SUVs Are Available Online 2Health News:Heavily Circulated Roads Can increase Auto Insurance Costs 2Health News:Visage Imaging Signs University of Florida Health 2Health News:Visage Imaging Signs University of Florida Health 3Health News:Visage Imaging Signs University of Florida Health 4
... By Maureen Salamon HealthDay Reporter , WEDNESDAY, ... improve patient safety, a six-year study at 10 North ... which included medical errors and unavoidable mistakes. ... randomly selected hospital admissions, teams of reviewers found 588 ...
... HealthDay Reporter , WEDNESDAY, Nov. 24 (HealthDay ... cancers aren,t diagnosed until the disease is well-advanced and, ... Almost one-half of colorectal cancers and cervical cancers ... are detected at a late stage, according to the ...
... light both the promise and the frustration of developing ... of skin cancer. Early clinical tests of a candidate ... results in patients whose cancers resisted all currently available ... invariably returned a few months later, able to withstand ...
... , WEDNESDAY, Nov. 24 (HealthDay News) -- A study ... lethal for blacks than it is for whites. In ... nearly one-fifth higher than it is for whites in that ... Office on Smoking and Health at the U.S. Centers for ...
... 24 It,s never fun riding the bench but could ... the future? That,s one of the questions being explored by ... Wilfrid Laurier University and the Canada Research Chair in Group Dynamics ... this week,s Canada Research Chairs conference in Toronto. Eys, ...
... London, UK, 24 November 2010 Research from ... ( http://www2.i-med.ac.at/psychlab/ ) at the Medical University Innsbruck ... in rats exhibited pathologies similar to Alzheimer,s disease. ... Neuroscience (45(4):408-417, 2010) with lead author Dr. ...
Cached Medicine News:Health News:Despite Efforts, Study Finds No Decline in Medical Errors 2Health News:Despite Efforts, Study Finds No Decline in Medical Errors 3Health News:Too Many Cancers Still Spotted Too Late: CDC 2Health News:Too Many Cancers Still Spotted Too Late: CDC 3Health News:Researchers shine light on how some melanoma tumors evade drug treatment 2Health News:Researchers shine light on how some melanoma tumors evade drug treatment 3Health News:Black Smokers May Face Higher Death Risk Than Whites: CDC 2Health News:Being a 'good sport' can be critical to maintaining lifelong physical activity 2Health News:Chronic high cholesterol diet produces brain damage 2
Easy to use practice management software....
... Practice Management software- ... system of Software, Support, ... offices of Optometry, Ophthalmology, ... streamlines office operations, allowing ...
... hematology system delivers a full ... for speed and accuracy, this ... with impressive productivity. The Advia ... its own or twinned with ...
The XT-1800i is a compact, high performance, automated hematology analyzer that provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test re...
Medicine Products: